RECENT NEWS

Zürich University Hospital has started using Stockholm3 for prostate cancer testing. This is the first clinic in Switzerland that uses Stockholm3.

More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next-generation sequencing (NGS) needs with the Biomek NGeniuS System.

Thermo Fisher Scientific has announced that it has entered into a definitive agreement to acquire The Binding Site Group, a global leader in specialty diagnostics, from a shareholder group led by European private equity firm Nordic Capital, in an all-cash transaction valued at £2.25 billion.

Three French university hospitals are to adopt the digital pathology solution from Sectra, joining forces to speed up cancer diagnostics.

The government has introduced a 12-month extension to the implementation of the future Medical Device Regulations, with an aim to bring the new regulations into force by July 2024.

Resolve Biosciences, the company which has pioneered Molecular Cartography technology, has announced it has secured a $71 million of financing to accelerate commercial expansion.

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, has opened a new state-of-the-art facility in Granta Park, Cambridgeshire, UK.

Matt Plocki re-joins the team at Validair Monitoring Solutions (VMSL), bringing huge experience to the company’s customers from previous roles in particle monitoring engineering development and hospital pharmaceutical manufacturing – as well as a former technical role at VMSL.

Milton Keynes University Hospital (MKUH) has held a series of test flights of drones carrying blood samples across its main site in Milton Keynes.

Enalees, a company specialising in the design, development and marketing of state-of-the-art rapid molecular diagnostic tests for the veterinary industry, has been awarded a €500,000 ($489k) subsidy by the Île-de-France region as part of the France 2030 Investments for the Future Program.

The UK’s efforts to tackle the monkeypox outbreak will receive a £2 million boost with the creation of a new research consortium.

Lab Innovations 2022 to share insight into the equipment and processes that are improving sustainability in the laboratory industry.

Beckman Coulter Life Sciences has introduced an automated solution for the gruelling and time-consuming process of manual gating flow cytometry data, with no programming skills required. This revolutionary feature is part of the new Cytobank v10 platform upgrade which is available now.

Technobis Crystallization Systems will be showcasing its new Crystal16 benchtop crystalliser, which allows scientists to obtain solubility data earlier in drug development.

The DiaSpect POC haemoglobin analyser is now powered by EKF Link digital connectivity solution, with secure POC connectivity.

New research has found that people can wait up to six years to be tested for heart failure after first presenting with key warning signs, due partly to delayed symptom recognition and a lack of testing in primary care.

The National Institute for Health and Care Research (NIHR) has awarded nearly £800 million to 20 Biomedical Research Centres across England, to translate scientific discoveries into new treatments, diagnostic tests and medical technologies to improve patients' lives.

Pathologists from Europe, Japan and the United States have jointly announced the debut of Digital Pathology Connections (DPC), a global community for professionals interested in the digital future of the anatomic pathology laboratory.

PerkinElmer contributes reliable, fast, and cost-efficient solutions to screen for the disease in collaboration with the Sickle Cell Foundation and Ghana Health Services.

NanoString Technologies, a leading provider of life science tools for discovery and translational research, and Visiopharm, a leader in AI-driven digital pathology software, have announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the latest spatial imaging and machine learning technologies.